Literature DB >> 19066343

Secretory meningiomas: a benign subgroup causing life-threatening complications.

Jan Regelsberger1, Christian Hagel, Pedram Emami, Thorsten Ries, Oliver Heese, Manfred Westphal.   

Abstract

While meningiomas are known as slow-growing extracerebral neoplasms, the subgroup of secretory meningiomas with histologically benign characteristics tend to cause disproportional peritumoral edema, frequently leading to severe medical and neurological complications in postoperative management. Among 1,484 meningiomas that were resected at our institution between 1990 and 2007, 44 (3%) patients were found to have the histological diagnosis of a secretory meningioma. The clinical course, radiological appearance, and histopathological features were retrospectively analyzed to examine the specifics of these benign lesions. Meningiomas were located at the convexity (n = 14), the cranial base (18), and the sphenoid ridge (12). A severe, nearly hemispheric perifocal edema disproportional to tumor size was seen on preoperative MR imaging in 18 (41%) patients. Following surgical resection, the postoperative course was uneventful in 29 patients. In 15 patients, severe peritumoral edema continued or even increased on postoperative CT imaging. Six patients showed midline shift and clinical worsening necessitating respirator-assisted ventilation and intracranial pressure monitoring. An association between the extent of brain edema and number of periodic acid Schiff-positive pseudopsammomas was found (p < 0.02). Further, the size of the edema correlated with the number of immunohistochemically detected cells expressing carcinoembryonic antigen (CEA) and cytokeratin (CK) (p < 0.01). Mean MIB-1 (Ki-67 antigen) proliferation index was 3.0% (range, 0%-17%) and did not correlate with edema or tumor recurrence. Secretory meningiomas are frequently associated with severe peritumoral edema. The extent of edema correlates with immunohistochemically detected expression of CEA and CK. Extended perifocal edema in meningiomas is an unusual finding and should alert the neurosurgeon that surgery may aggravate edema excessively, leading to a life-threatening postoperative situation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19066343      PMCID: PMC2802401          DOI: 10.1215/15228517-2008-109

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  14 in total

1.  Secretory meningioma, a rare meningioma subtype with characteristic glandular differentation: an histological and immunohistochemical study of 9 cases.

Authors:  A Assi; P Declich; M Iacobellis; L Cozzi; G Tonnarelli
Journal:  Adv Clin Path       Date:  1999-07

2.  Secretory meningioma.

Authors:  G C Ejeckam; B Azadeh; A Hamad
Journal:  Histopathology       Date:  1992-11       Impact factor: 5.087

3.  Secretory meningioma: clinicopathologic features of eight cases.

Authors:  S Nishio; T Morioka; S Suzuki; K Hirano; M Fukui
Journal:  J Clin Neurosci       Date:  2001-07       Impact factor: 1.961

4.  Secretory meningioma. A distinct subtype of meningioma.

Authors:  A Alguacil-Garcia; N M Pettigrew; A A Sima
Journal:  Am J Surg Pathol       Date:  1986-02       Impact factor: 6.394

5.  Secretory meningiomas: clinical and immunohistochemical observations.

Authors:  R Buhl; H H Hugo; Z Mihajlovic; H M Mehdorn
Journal:  Neurosurgery       Date:  2001-02       Impact factor: 4.654

6.  [An immunohistochemical and ultrastructural study on 76 cases of meningioma].

Authors:  K F Liu
Journal:  Zhonghua Bing Li Xue Za Zhi       Date:  1989-12

Review 7.  Brain oedema in secretory meningiomas.

Authors:  R Buhl; H H Hugo; H M Mehdorn
Journal:  J Clin Neurosci       Date:  2001-05       Impact factor: 1.961

8.  Stromelysin-3 is expressed by aggressive meningiomas.

Authors:  Anne Gentil Perret; Robert Duthel; Marie-Jeanette Fotso; Jacques Brunon; Jean-François Mosnier
Journal:  Cancer       Date:  2002-02-01       Impact factor: 6.860

Review 9.  Merlin expression in secretory meningiomas: evidence of an NF2-independent pathogenesis? Immunohistochemical study.

Authors:  Anna Maria Buccoliero; Chiara Francesca Gheri; Francesca Castiglione; Franco Ammannati; Pasquale Gallina; Antonio Taddei; Francesca Garbini; Duccio Rossi Degl'Innocenti; Luisa Arganini; Nicola Di Lorenzo; Pasquale Mennonna; Gian Luigi Taddei
Journal:  Appl Immunohistochem Mol Morphol       Date:  2007-09

10.  Mapping of the keratin polypeptides in meningiomas of different types: an immunohistochemical analysis of 463 cases.

Authors:  Markku Miettinen; Anders Paetau
Journal:  Hum Pathol       Date:  2002-06       Impact factor: 3.466

View more
  12 in total

1.  Clinical features, surgical management, and prognostic factors of secretory meningiomas: a single-center case series of 149 patients.

Authors:  Xiaogang Tao; Kun Wang; Jinqian Dong; Zonggang Hou; Zhen Wu; Junting Zhang; Baiyun Liu
Journal:  J Neurooncol       Date:  2017-11-15       Impact factor: 4.130

Review 2.  Pathogenesis of peri-tumoral edema in intracranial meningiomas.

Authors:  Moncef Berhouma; Timothee Jacquesson; Emmanuel Jouanneau; François Cotton
Journal:  Neurosurg Rev       Date:  2017-08-24       Impact factor: 3.042

3.  Secretory meningiomas: clinical, radiological and pathological findings in 70 consecutive cases at one institution.

Authors:  Dai-Jun Wang; Qing Xie; Ye Gong; Yin Wang; Hai-Xia Cheng; Ying Mao; Ping Zhong; Feng-Ping Huang; Kang Zheng; Yong-Fei Wang; Wei-Min Bao; Bo-Jie Yang; Hong Chen; Li-Qian Xie; Ming-Zhe Zheng; Hai-Liang Tang; Hong-Da Zhu; Xian-Cheng Chen; Liang-Fu Zhou
Journal:  Int J Clin Exp Pathol       Date:  2013-02-15

4.  Anatomical configuration of the Sylvian fissure and its influence on outcome after pterional approach for microsurgical aneurysm clipping.

Authors:  Hannah M Ngando; Homajoun Maslehaty; Lutz Schreiber; Klaus Blaeser; Martin Scholz; Athanasios K Petridis
Journal:  Surg Neurol Int       Date:  2013-09-30

5.  Factors affecting peritumoral brain edema in meningioma: special histological subtypes with prominently extensive edema.

Authors:  Tadashi Osawa; Masahiko Tosaka; Masaya Nagaishi; Yuhei Yoshimoto
Journal:  J Neurooncol       Date:  2012-10-27       Impact factor: 4.130

6.  Expression of aquaporin 5 and the AQP5 polymorphism A(-1364)C in association with peritumoral brain edema in meningioma patients.

Authors:  Nicole Lambertz; Nicolai El Hindy; Cordula Adler; Katharina Rump; Michael Adamzik; Kathy Keyvani; Agnes Bankfalvi; Winfried Siffert; I Erol Sandalcioglu; Hagen S Bachmann
Journal:  J Neurooncol       Date:  2013-02-08       Impact factor: 4.130

7.  Crush Cytology of Secretory Meningioma: A Case Report.

Authors:  Na Rae Kim; Gie-Taek Yee; Hyun Yee Cho
Journal:  Brain Tumor Res Treat       Date:  2015-10-30

Review 8.  Meningioma.

Authors:  Ali-Reza Fathi; Ulrich Roelcke
Journal:  Curr Neurol Neurosci Rep       Date:  2013-04       Impact factor: 5.081

9.  Expression of mesothelioma-related markers in meningiomas: an immunohistochemical study.

Authors:  Eman Abdelzaher; Dina Mohamed Abdallah
Journal:  Biomed Res Int       Date:  2014-04-30       Impact factor: 3.411

10.  KLF4K409Q-mutated meningiomas show enhanced hypoxia signaling and respond to mTORC1 inhibitor treatment.

Authors:  Niklas von Spreckelsen; Natalie Waldt; Rebecca Poetschke; Christoph Kesseler; Hildegard Dohmen; Hui-Ke Jiao; Attila Nemeth; Stefan Schob; Cordula Scherlach; Ibrahim Erol Sandalcioglu; Martina Deckert; Frank Angenstein; Boris Krischek; Pantelis Stavrinou; Marco Timmer; Marc Remke; Elmar Kirches; Roland Goldbrunner; E Antonio Chiocca; Stefan Huettelmaier; Till Acker; Christian Mawrin
Journal:  Acta Neuropathol Commun       Date:  2020-04-03       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.